AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-making

Key Points

• Real-world evidence standards could facilitate better pharmaceutical coverage decisions by US payers.
• Current barriers include insufficient guidance and assessment standards specific to payer needs.
• Developing workable standards for real-world evidence is essential for enhancing reimbursement strategies.
• This initiative highlights the importance of integrating real-world evidence into payer decision-making processes.